These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3053205)

  • 1. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
    Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
    Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
    Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
    Shaw P; Buckman R; Law J; Baumal R; Marks A
    Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
    Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
    J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.
    Mottolese M; Venturo I; Rinaldi M; Lopez M; Bigotti G; Benevolo M; Natali PG
    Br J Cancer; 1997; 75(4):572-8. PubMed ID: 9052413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
    Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
    Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
    Delahaye M; Hoogsteden HC; Van der Kwast TH
    J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions.
    Magyarosy E; Martin WJ; Chu EW; Martin SE
    Pathol Oncol Res; 1999; 5(1):32-5. PubMed ID: 10079375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of the determination of carcinoembryonic antigens with monoclonal antibodies in abdominal and pleural effusion].
    Fei XF
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):28-9, 62. PubMed ID: 2379252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma.
    Osinaga E; Pancino G; Beuzelin M; Babino A; Rodriguez D; Robello C; Tiscornia A; Phillips E; Bourguignat A; Roseto A
    Cancer; 1992 Apr; 69(7):1745-9. PubMed ID: 1551059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a pool of monoclonal antibodies in diagnosing cells from serous cavities.
    Cappellari A; Bagarella M; Ménard S; Calabrese M; Colnaghi MI
    Tumori; 1993 Jun; 79(3):211-3. PubMed ID: 8236507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
    Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
    Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies.
    Ménard S; Rilke F; Della Torre G; Mariani-Costantini R; Regazzoni M; Tagliabue E; Alasio L; Colnaghi MI
    Am J Clin Pathol; 1985 May; 83(5):571-6. PubMed ID: 3887893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum CA 125 levels in patients with benign ascitic or pleural effusions.
    Mezger J; Wilmanns W; Lamerz R
    Tumour Biol; 1988; 9(1):47-52. PubMed ID: 3163160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
    Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
    Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.